Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Recruiting now · Phase 2

Conditions studied: Cancer, Period Problem

In brief

The purpose of this study is to find out whether it is practical (feasible) to use acupuncture to treat period loss (amenorrhea) caused by chemotherapy treatment in people with cancer. The researchers will look at how many participants enroll and complete the study. The researchers will also study how treatment with acupuncture affects the amount of time for the menstrual cycle to return and symptoms and quality of life related to amenorrhea.

Key facts

Study ID

NCT06915116

Run by

Memorial Sloan Kettering Cancer Center

People needed

60

Starts

2025-03-31

Expected to finish

2027-03-31

Last updated by the study team

2026-04-14

Who can join

Age: 15 and older, up to 40. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• English speaking woman between the ages of 15 and 40
• History of stage I, II, or III cancer OR stage IV or unstaged hematologic malignancy (e.g. lymphoma, leukemia, myeloma) that is stable, as assessed by care team
• Premenopausal status with regular menstruation at the time of diagnosis by patient report
• Completed cytotoxic chemotherapy within the past year
• Premenopausal status with regular menstruation at the time of diagnosis by patient report for females ages 18 or older
• Report cessation of menses during or after chemotherapy and have not experienced menses recovery at the time of enrollment.
• Have reached menarche prior to therapy or during therapy for females between 15 and 17 years old
• Patient reports cessation of menses during or after chemotherapy and have not experienced menses recovery at the time of enrollment.
• Have been without menses for at least 3 months 64 following the completion of cytotoxic chemotherapy
• Willing to adhere to all study-related procedures, including randomization to one of the two possible arms: acupuncture and WLC

You may not qualify if…

• Had been pregnant or lactating within 3 months prior to enrollment
• History of hysterectomy or bilateral oophorectomy
• Ongoing or planned radiation or surgery within 4 months from randomization
• Use of acupuncture for menses recovery within 3 months of enrollment
• Had been or will be receiving ovarian suppression medicine, such as leuprolide (Lupron) and goserelin (Zoladex), or hormonal contraception drugs within 3 months of enrollment or during the study period

Where it is running

• Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey, United States (enrolling)
• Memorial Sloan Kettering Monmouth (All protocol activities) — Middletown, New Jersey, United States (enrolling)
• Memorial Sloan Kettering Bergen (All Protocol Activities) — Montvale, New Jersey, United States (enrolling)
• Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) — Commack, New York, United States (enrolling)
• Memorial Sloan Kettering Westchester (All Protocol Activities) — Harrison, New York, United States (enrolling)
• Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York, United States (enrolling)
• Memorial Sloan Kettering Nassau (All Protocol Activities) — Rockville Centre, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.